Phosphatidylserine in Diabetes Research

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Phospholipids are crucial for cell membrane structure and function.
• Diabetes is a complex metabolic disease linked to altered phospholipid levels and insulin sensitivity.
• Phosphatidylserine (PS) has demonstrated significant cellular roles in the context of diabetes.

Purpose of the Study:

• To review and summarize the regulatory roles of phosphatidylserine (PS) in diabetes and insulin sensitivity.
• To explore the therapeutic potential of PS and PS-containing liposomes for treating diabetes and its complications.

Main Methods:

• Literature review of recent studies on PS, diabetes, and insulin sensitivity.
• Analysis of PS involvement in insulin secretion, signaling, and diabetic complications.
• Evaluation of animal studies on PS supplementation and liposomal PS for diabetes treatment.

Main Results:

• PS is implicated in controlling insulin secretion and regulating insulin signaling transduction.
• PS contributes to diabetic complications by affecting microvascular coagulation and targeting mitochondria.
• Dietary PS and PS-liposomes showed protective effects against type 1 and type 2 diabetes in animal models.

Conclusions:

• Phosphatidylserine (PS) exhibits multifaceted roles in diabetes pathogenesis and progression.
• PS and PS-based liposomes represent promising therapeutic strategies for diabetes and its associated complications.
• Further research into PS mechanisms can advance diabetes treatment and drug development.